Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
B75-H5258 | Human | Human B7-H5 / Gi24 / VISTA Protein, Mouse IgG2a Fc Tag, low endotoxin |
|
||
B75-H82F3 | Human | Biotinylated Human B7-H5 / Gi24 / VISTA Protein, Fc,Avitag™ |
|
||
B75-M52H7 | Mouse | Mouse B7-H5 / Gi24 / VISTA Protein, His Tag |
|
||
B75-C5220 | Rhesus macaque | Rhesus macaque B7-H5 / Gi24 / VISTA Protein, His Tag |
|
||
B75-H82E1 | Human | Biotinylated Human B7-H5 / Gi24 / VISTA Protein, Avitag™,His Tag |
|
||
B75-H5259 | Human | Human B7-H5 / Gi24 / VISTA Protein, Fc Tag |
|
||
B75-H52H0 | Human | Human B7-H5 / Gi24 / VISTA Protein, His Tag (MALS verified) |
|
Human B7-H5 Protein, Mouse IgG2a Fc Tag (Cat. No. B75-H5258) Captured on CM5 chip via anti-mouse antibodies surface can bind Human VSIG3, Fc Tag (Cat. No. VS3-H5258) with an affinity constant of 8.87 μM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
SNS-101 (Sensei-Biotherapeutics) | Phase 2 Clinical | Sensei Biotherapeutics, Inc | Solid tumours | Details | |
KVA-12123 | KVA-12123; KVA-12.1 | Phase 2 Clinical | GigaGen Inc | Neoplasms; Melanoma; Lung Neoplasms; Thyroid Neoplasms; Uterine Neoplasms; Colorectal Neoplasms; Sarcoma; Breast Neoplasms; Prostatic Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma; Solid tumours; Kidney Neoplasms; Head and Neck Neoplasms | Details |
Onvatilimab | CI-8993; JNJ-61610588 | Phase 1 Clinical | Johnson & Johnson Innovative Medicine, Immunext Inc | Solid tumours; Neoplasms | Details |
HMBD-002 | HMBD-002 | Phase 1 Clinical | Hummingbird Bioscience | Solid tumours; Triple Negative Breast Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
PMC-309 | PMC-309 | Phase 1 Clinical | Pharmabcine | Solid tumours; Neoplasms | Details |
CA-170 | CA-170; AUPM-170 | Phase 1 Clinical | Aurigene | Solid tumours | Details |
This web search service is supported by Google Inc.